Quote | Context Therapeutics Inc. (NASDAQ:CNTX)
Last: | $1.4101 |
---|---|
Change Percent: | -2.9% |
Open: | $1.42 |
Close: | $1.4101 |
High: | $1.4498 |
Low: | $1.37 |
Volume: | 19,984 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Context Therapeutics Inc. (NASDAQ:CNTX)
2024-04-01 09:11:44 ET More on Context Therapeutics Seeking Alpha’s Quant Rating on Context Therapeutics Historical earnings data for Context Therapeutics Financial information for Context Therapeutics Read the full article on Seeking Alpha For...
PHILADELPHIA, April 01, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced that on March 28, 2024, the Company submitted an Investigational Ne...
Message Board Posts | Context Therapeutics Inc. (NASDAQ:CNTX)
Subject | By | Source | When |
---|---|---|---|
$CNTX .65. Just needs to squeeze back | BooDog | investorshub | 04/18/2023 12:07:20 PM |
Nice pop! Summertime's coming!!! | BooDog | investorshub | 04/04/2023 5:23:44 PM |
(1) The purchases reported in this Form 4 | BooDog | investorshub | 02/14/2023 1:04:09 PM |
Thank you for all your DD. I can't | vegasopc | investorshub | 02/03/2023 12:53:48 PM |
I dug even deeper... The merger between Stemline | BooDog | investorshub | 02/03/2023 12:39:20 PM |
News, Short Squeeze, Breakout and More Instantly...
Context Therapeutics Inc. Company Name:
CNTX Stock Symbol:
NASDAQ Market:
PHILADELPHIA, April 01, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced that on March 28, 2024, the Company submitted an Investigational Ne...
CTIM-76 IND filing on track for late March 2024 Cash and cash equivalents of $14.4 million as of December 31, 2023 Company expects its cash and cash equivalents will continue to fund operations into late 2024 PHILADELPHIA, March 21, 2024 (GLOBE NEWSWIRE) -- Context Therape...
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter finan...